Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 15719405)

Published in Liver Transpl on March 01, 2005

Authors

Marianne Samyn1, Paul Cheeseman, Lynsey Bevis, Rachel Taylor, Beatrice Samaroo, Muriel Buxton-Thomas, Nigel Heaton, Mohamed Rela, Giorgina Mieli-Vergani, Anil Dhawan

Author Affiliations

1: Department of Child Health, King's College Hospital, Denmark Hill, London, UK.

Articles by these authors

Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27

Acute liver failure. Lancet (2010) 3.39

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91

Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology (2014) 2.29

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation (2005) 2.23

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23

Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17

Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl (2008) 1.97

Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology (2008) 1.95

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr (2012) 1.91

Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology (2009) 1.90

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83

Antenatal presentation of biliary atresia. J Pediatr (2004) 1.82

Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology (2006) 1.80

Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77

Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology (2007) 1.76

Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr (2003) 1.75

A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl (2005) 1.75

Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol (2006) 1.70

Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68

C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet (2008) 1.64

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol (2009) 1.61

Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol (2010) 1.60

Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology (2002) 1.58

Liver transplantation for propionic acidemia in children. Liver Transpl (2011) 1.56

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54

A genetic study of Wilson's disease in the United Kingdom. Brain (2013) 1.53

Can energy expenditure be predicted in critically ill children?. Pediatr Crit Care Med (2003) 1.52

Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology (2010) 1.51

Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr (2008) 1.48

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47

Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J Pediatr Gastroenterol Nutr (2007) 1.47

Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology (2011) 1.44

Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol (2007) 1.44

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol (2005) 1.44

Teaching about tobacco in medical schools: a worldwide study. Drug Alcohol Rev (2009) 1.44

Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43

Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43

Assessing nutritional status in children with chronic liver disease. J Gastroenterol Hepatol (2005) 1.43

The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr (2006) 1.42

Live organ-donation for islet transplantation. Lancet (2005) 1.40

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology (2005) 1.40

Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39

Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant (2012) 1.38

New Zealand's shocking diabetes rates can be reduced--9 urgently needed actions. N Z Med J (2011) 1.38

Autoimmune hepatitis. J Hepatol (2010) 1.38

Is single-port laparoscopy feasible after liver transplant? Pediatr Transplant (2013) 1.37

Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood (2002) 1.34

Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31

Current status of hepatocyte transplantation. Transplantation (2012) 1.28

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18

Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr (2009) 1.17

Autoimmune hepatitis: a comprehensive review. J Autoimmun (2012) 1.16

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate. Cancer Immunol Immunother (2005) 1.16

Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15

The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15

Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl (2005) 1.13

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr (2010) 1.13

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13